Left Shoulder Fungating Mass in a 46-Year-Old Man
- 15 June 2023
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 9 (8) , 1142-1143
Abstract
A 46-year-old man presented with a left shoulder mass. It began with a quarter-size maculopapular lesion and continued to progress during the next 3 years. He reported limited shoulder movements and denied other symptoms. There was no medical or surgical history, and he had a negative personal or familial oncologic history. The patient was a construction worker and used tobacco daily. On physical examination, there was a 24 × 15-cm fungating, necrotic, and ulcerated left shoulder mass (Figure 1A). A punch biopsy showed sheets of highly pleomorphic atypical spindle and epithelial cells within the superficial and deep dermis, extending into the subcutaneous tissue, and with 18 mitoses/mm2. Immunohistochemistry demonstrated SOX10-positive and pankeratin-negative tumor cells. A whole-body positron emission tomographic and computed tomographic scan revealed an intensely hypermetabolic left shoulder mass and multiple hypermetabolic enlarged left axillary lymph nodes, with no distant metastases (Figure 1B). Brain magnetic resonance imaging was negative for intracranial metastasis.Keywords
This publication has 8 references indexed in Scilit:
- Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced MelanomaNew England Journal of Medicine, 2023
- Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trialNature Medicine, 2022
- Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III MelanomaJAMA Surgery, 2022
- Surgical removal of the index node marked using magnetic seed localization to assess response to neoadjuvant immunotherapy in patients with stage III melanomaBritish Journal of Surgery, 2019
- Annals of Palliative Medicine2016
- A Newly Developed Mouse Monoclonal SOX10 Antibody Is a Highly Sensitive and Specific Marker for Malignant Melanoma, Including Spindle Cell and Desmoplastic MelanomasArchives of Pathology & Laboratory Medicine, 2014
- Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialThe Lancet Oncology, 2012
- Large Neglected Ulcerated Melanoma Mimicking Extramedullary PlasmacytomaThe American Journal of Dermatopathology, 2011